U.S. Markets closed

Today's Research Reports on Trending Tickers: AstraZeneca and AbbVie

NEW YORK, NY / ACCESSWIRE / November 20, 2018 / Wall Street posted sharp losses on Monday as drop in information technology shares and pressured broader market lower. The Dow Jones Industrial Average was down 1.56 percent to close at 25,017.44, while the S&P 500 Index decreased 1.66 percent to close at 2,690.73. The Nasdaq Composite Index finished 3.03 percent lower at 7,028.48.

“Tech continues to be caught in the crosshairs of the triple threat of rising interest rates, global growth fears and trade tensions with China,” according to a chief investment officer at Independent Advisor Alliance, Chris Zaccarelli. “Trade war concerns with China weigh on the global supply chain for large technology companies while global growth fears worry many that future earnings will be lower,” Zaccarelli added.

The Market Edge Initiates Coverage on:

AstraZeneca PLC
https://marketedgereport.com/report/AZN/

AbbVie Inc.
https://marketedgereport.com/report/ABBV/

AstraZeneca's stock moved 0.32% higher Monday, to close the day at $40.80. The stock recorded a trading volume of 6,167,488 shares, which was above its three months average volume of 4,245,535 shares. In the last year, AstraZeneca's shares have traded in a range of 31.99 - 41.78. The share price has gained 27.54% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $37.66 is above its 200-day moving average of $39.13. Shares of the company are trading at a Price to Earnings ratio of 38.67. Shares of AstraZeneca have gained roughly 4.06 percent in the past month and are up 17.58 percent year-to-date.

Access The Market Edge’s AstraZeneca PLC Research Report at:
https://marketedgereport.com/report/AZN/

On Monday, shares of AbbVie recorded a trading volume of 5,971,688 shares, which was above the three months average volume of 6,027,276 shares. The stock ended the day 2.24% lower at $89.48. The share price has fallen 28.91% from its 52 week high with a 52 week trading range of 81.50 - 125.86. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $92.77 is below its 200-day moving average of $95.85. Shares of the company are trading at a Price to Earnings ratio of 18.69. Shares of AbbVie have gained roughly 1.72 percent in the past month and are down 7.48 percent year-to-date.

Access The Market Edge’s AbbVie Inc. Research Report at:
https://marketedgereport.com/report/ABBV/

Our Actionable Research on AstraZeneca PLC (NYSE : AZN ) and AbbVie Inc. (NYSE : ABBV ) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: MarketEdgeReport